SUSCEPTIBILITY OF MORAXELLA-CATARRHALIS TO 21 ANTIMICROBIAL DRUGS - VALIDITY OF CURRENT NCCLS CRITERIA FOR THE INTERPRETATION OF AGAR DISH DIFFUSION ANTIBIOGRAMS
Wh. Traub et B. Leonhard, SUSCEPTIBILITY OF MORAXELLA-CATARRHALIS TO 21 ANTIMICROBIAL DRUGS - VALIDITY OF CURRENT NCCLS CRITERIA FOR THE INTERPRETATION OF AGAR DISH DIFFUSION ANTIBIOGRAMS, Chemotherapy, 43(3), 1997, pp. 159-167
Ninety-four clinical isolates of Moraxella catarrhalis were examined f
or susceptibility to 21 antimicrobial drugs; 67 isolates (= 71.3 %) pr
oduced beta-lactamase(s). In terms of antibiotic resistance, the numbe
r of isolates resistant to penicillin G, ampicillin, and cotrimoxazole
were 56, 32, and 1, respectively. The number of isolates with interme
diate susceptibility to penicillin G, ampicillin, ciprofloxacin, oflox
acin, cotrimoxazole, and fosfomycin were 11, 34, 1, 2, 2, and 47, resp
ectively. All 94 isolates proved susceptible to ampicillin + 10 mu g/m
l of sulbactam, amoxicillin + 4 mu g/ml of clavulanic acid, cefuroxime
, cefotaxime, cefepime, cefixime, imipenem, meropenem, chloramphenicol
, doxycycline, tetracycline, fusidic acid, erythromycin, clarithromyci
n, and rifampin, as based on currently valid NCCLS criteria, where app
licable. There were no very major or major discrepancies between agar
dilution and agar disk diffusion test results. There were only a few m
inor discrepancies between test results, specifically: penicillin G (c
ategory IV = 4, category VI = 1); ampicillin (category IV = 4, categor
y V = 1, category VI 7), amoxicillin + clavulanic acid (category III =
11), cotrimoxazole (category IV = 1, category V = 1, category VI = 1)
, ciprofloxacin (category V = 1), and ofloxacin (category VI = 2). The
sole exception was fosfomycin, with a total of 25 minor discrepancies
encountered (category III = 14, category V = 9, category VI = 2). Wil
kins-Chalgren agar compared favorably with Mueller-Hinton agar followi
ng examination with 11 selected antimicrobial drugs against 31 represe
ntative isolates of M. catarrhalis.